PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsRVL Pharmaceuticals
RVL Pharmaceuticals(RVLP)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
UpneeqOxymetazoline2020-07-082024-2039
Common cold
,
Conjunctivitis
,
Rhinitis
,
Sinusitis
DonepezilDonepezil2016-01-262025-2038
Alzheimer disease
HydromorphoneHydromorphone2016-07-072032-2034
Cough
,
Postoperative pain
NifedipineNifedipine2005-11-21
Hypertension,
Stable angina,
Variant angina pectoris
OxybutyninOxybutynin2009-02-042029-2031
Urge urinary incontinence,
Dysuria,
Neurogenic urinary bladder,
Urinary incontinence
RelexxiiMethylphenidate2022-06-232024-2038
Attention deficit disorder with hyperactivity,
Depressive disorder,
Narcolepsy
MethylphenidateMethylphenidate2017-07-282024-2038
Attention deficit disorder with hyperactivity,
Depressive disorder,
Narcolepsy
VenlafaxineVenlafaxine2008-05-202023-2028
Attention deficit disorder with hyperactivity,
Autistic disorder,
Chronic fatigue syndrome,
Depressive disorder,
Obsessive-compulsive disorder,
Pain
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Oxymetazoline
blepharoptosis
Arbaclofen
multiple sclerosis
,
muscle spasticity
Alfacalcidol
blepharoptosis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use